Technical Analysis for BHVN - Biohaven Pharmaceutical Holding Company Ltd.

Grade Last Price % Change Price Change
grade B 38.95 4.56% 1.70
BHVN closed up 4.56 percent on Thursday, September 20, 2018, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical BHVN trend table...

Date Alert Name Type % Chg
Sep 20 Bollinger Band Squeeze Range Contraction 0.00%
Sep 20 BB Squeeze + Upper Band Touch Range Contraction 0.00%
Sep 20 Above Upper BB Strength 0.00%
Sep 20 Up 3 Days in a Row Strength 0.00%
Sep 20 Upper Bollinger Band Touch Strength 0.00%
Sep 19 20 DMA Support Bullish 4.56%
Sep 19 Bollinger Band Squeeze Range Contraction 4.56%
Sep 19 NR7 Range Contraction 4.56%
Sep 18 Crossed Above 20 DMA Bullish 5.53%
Sep 18 Crossed Above 50 DMA Bullish 5.53%

Older signals for BHVN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Biohaven Pharmaceutical Holding Company Ltd. is a United States-based biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. It has a portfolio of multiple late-stage drug candidates. Its pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity (NCE) that modulates glutamate, and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate (NMDA) receptor antagonism. Its clinical compound, trigriluzole, is indicated for neurodegenerative diseases and cancer indications, among others. Its pipeline also includes BHV-3000 and BHV-3500, which are in-licensed by the Company for a neurologic indication. It focuses on advancing other mechanistic approaches in orphan and neuroscience indications, and is exploring licenses for additional compounds.
Is BHVN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 44.28
52 Week Low 16.5
Average Volume 240,671
200-Day Moving Average 31.905
50-Day Moving Average 36.0254
20-Day Moving Average 36.8295
10-Day Moving Average 36.921
Average True Range 1.5893
ADX 15.72
+DI 26.7383
-DI 14.7344
Chandelier Exit (Long, 3 ATRs ) 34.2221
Chandelier Exit (Short, 3 ATRs ) 38.5279
Upper Bollinger Band 38.8614
Lower Bollinger Band 34.7976
Percent B (%b) 1.02
BandWidth 11.03409
MACD Line 0.4604
MACD Signal Line 0.3048
MACD Histogram 0.1556
Fundamentals Value
Market Cap 1.4 Billion
Num Shares 35.8 Million
EPS -7.54
Price-to-Earnings (P/E) Ratio -5.17
Price-to-Sales 0.00
Price-to-Book 5.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.06
Resistance 3 (R3) 41.72 40.36 41.54
Resistance 2 (R2) 40.36 39.57 40.52 41.36
Resistance 1 (R1) 39.65 39.08 40.01 39.99 41.19
Pivot Point 38.29 38.29 38.46 38.45 38.29
Support 1 (S1) 37.58 37.50 37.94 37.92 36.71
Support 2 (S2) 36.22 37.01 36.38 36.54
Support 3 (S3) 35.51 36.22 36.36
Support 4 (S4) 35.85